1. Home
  2. BNGO vs AMS Comparison

BNGO vs AMS Comparison

Compare BNGO & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNGO
  • AMS
  • Stock Information
  • Founded
  • BNGO 2003
  • AMS 1980
  • Country
  • BNGO United States
  • AMS United States
  • Employees
  • BNGO N/A
  • AMS N/A
  • Industry
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • AMS Medical Specialities
  • Sector
  • BNGO Industrials
  • AMS Health Care
  • Exchange
  • BNGO Nasdaq
  • AMS Nasdaq
  • Market Cap
  • BNGO 24.3M
  • AMS 21.1M
  • IPO Year
  • BNGO 2018
  • AMS N/A
  • Fundamental
  • Price
  • BNGO $0.19
  • AMS $3.13
  • Analyst Decision
  • BNGO Hold
  • AMS
  • Analyst Count
  • BNGO 3
  • AMS 0
  • Target Price
  • BNGO $1.00
  • AMS N/A
  • AVG Volume (30 Days)
  • BNGO 16.7M
  • AMS 11.7K
  • Earning Date
  • BNGO 03-04-2025
  • AMS 11-13-2024
  • Dividend Yield
  • BNGO N/A
  • AMS N/A
  • EPS Growth
  • BNGO N/A
  • AMS 779.12
  • EPS
  • BNGO N/A
  • AMS 0.61
  • Revenue
  • BNGO $33,334,000.00
  • AMS $24,969,000.00
  • Revenue This Year
  • BNGO N/A
  • AMS $27.74
  • Revenue Next Year
  • BNGO $6.18
  • AMS $17.72
  • P/E Ratio
  • BNGO N/A
  • AMS $5.27
  • Revenue Growth
  • BNGO N/A
  • AMS 20.83
  • 52 Week Low
  • BNGO $0.17
  • AMS $2.51
  • 52 Week High
  • BNGO $1.36
  • AMS $4.60
  • Technical
  • Relative Strength Index (RSI)
  • BNGO 39.40
  • AMS 47.32
  • Support Level
  • BNGO $0.17
  • AMS $3.03
  • Resistance Level
  • BNGO $0.26
  • AMS $3.26
  • Average True Range (ATR)
  • BNGO 0.05
  • AMS 0.12
  • MACD
  • BNGO -0.01
  • AMS 0.00
  • Stochastic Oscillator
  • BNGO 7.38
  • AMS 27.78

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

Share on Social Networks: